# In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides

> **NCT02159937** · — · COMPLETED · sponsor: **Recepta Biopharma** · enrollment: 33 (actual)

## Conditions studied

- Metastatic Cancer

## Interventions

- **OTHER:** Blood sampling by vena punction.

## Key facts

- **NCT ID:** NCT02159937
- **Lead sponsor:** Recepta Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2015-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02159937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02159937, "In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02159937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*